About VeGen
VeGen is a Healthcare company based in Hyderabad (India) founded in 2021 by Prashant Bhavar and Uday Kumar. Therapeutics for lung, colorectal, and pancreatic cancers are developed. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity in India is Vegen Labs Llp (AAX-5981).
Company details
VeGen was founded in 2021 and is based in Hyderabad, India. Therapeutics for cancer patients are developed by the company within the biotechnology sector. A pipeline of drug candidates is maintained, including IND126 targeted at lung cancer and colorectal cancer, KRAS12D for pancreatic cancer, and additional candidates. Operations focus on advancing these treatments through research and development stages.
- Headquarters Hyderabad, India
- Founders Prashant Bhavar, Uday Kumar
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vegen.in
- Social LinkedIn
- Legal Name Vegen Labs Llp
- Date of Incorporation 30 Jun, 2021
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue$36.24 K (USD)127as on Mar 31, 2024
- Net Profit-$1.05 K (USD)-360as on Mar 31, 2024
- EBITDA-$945.48 (USD)-749as on Mar 31, 2024
- Latest Funding Round$430.41K (USD), Grant
Mar 2025
- Investors
Associated legal entities of VeGen
VeGen operates through Vegen Labs Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vegen Labs Llp CIN AAX-5981 | Active | 30 Jun 2021 | Hyderabad, Telangana | 2 | View details |
Funding Insights of VeGen
- Total Rounds 1
- Last Round Grant — $430,415
- First Round $430,415
(Mar 2025)
- Investors Count 1
All 1 funding rounds of VeGen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $430,415 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in VeGen
VeGen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BIRAC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Business incubation services are provided across multiple sectors. | birac.nic.in | Delhi, India |
Investor details for VeGen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Vegen Labs Llp (VeGen)
Vegen Labs Llp is the primary company behind VeGen. The board of Vegen Labs Llp currently have 2 directors; the longest-serving is Uday Kumar Surampudi, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Uday Kumar Surampudi DIN 09221336 | Designated Partner | 30 Jun 2021 | 5 yrs 4 mo | Vegen Labs Llp |
| Prashant Kashinath Bhavar DIN 09221337 | Designated Partner | 30 Jun 2021 | 5 yrs 4 mo | Vegen Labs Llp |
People of VeGen
2 people are tracked at VeGen (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for VeGen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VeGen
2 dated milestones of VeGen across 4 years, from founding to its latest funding, stage changes and deals.
- Founded VeGen is founded.
- Funding First funding round of $430K.
Web traffic of VeGen
The website of VeGen (vegen.in) receives about 4.3K visits a month.
- Monthly visits4.3K
▲ 62.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vegen
Complete news archive for VeGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VeGen
VeGen was founded in 2021 and raised its 1st funding round 4 years after it was founded.
VeGen is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of VeGen is $36.24K as on Mar 31, 2024.
VeGen was founded in 2021 and is based in Hyderabad, India. Therapeutics for cancer patients are developed by the company within the biotechnology sector. A pipeline of drug candidates is maintained, including IND126 targeted at lung cancer and colorectal cancer, KRAS12D for pancreatic cancer, and additional candidates. Operations focus on advancing these treatments through research and development stages.
VeGen has 1 investor. Key investors include BIRAC.
VeGen operates through Vegen Labs Llp.
The legal entities of VeGen currently have 2 directors, including Uday Kumar Surampudi, Prashant Kashinath Bhavar.